The use of PGs in human reproduction.
D000028:Abortion, Induced; D002584:Cervix Uteri / Q000187:drug effects; D003338:Corpus Luteum / Q000187:drug effects; D004412:Dysmenorrhea / Q000188:drug therapy; D005260:Female; D006801:Humans; D007751:Labor, Induced; D008297:Male; D007752:Obstetric Labor, Premature / Q000517:prevention & control; D009774:Obstetrics; D010121:Oxytocin / Q000008:administration & dosage / Q000627:therapeutic use; D006473:Postpartum Hemorrhage / Q000517:prevention & control; D011247:Pregnancy; D011261:Pregnancy Trimester, First; D011262:Pregnancy Trimester, Second; D011448:Prostaglandin Antagonists / Q000627:therapeutic use; D011453:Prostaglandins / Q000008:administration & dosage / Q000138:chemical synthesis / Q000494:pharmacology / Q000627:therapeutic use; D011465:Prostaglandins, Synthetic / Q000627:therapeutic use; D014599:Uterus / Q000187:drug effects
D011448:Prostaglandin Antagonists; D011453:Prostaglandins; D011465:Prostaglandins, Synthetic; D010121:Oxytocin